Close Menu

NEW YORK (GenomeWeb) — German molecular diagnostics firm Curetis said today that it will receive €6.5 million ($7.3 million) in gross proceeds under two financing facilities.

According to Curetis, it will receive a €5.0 million tranche of non-dilutive debt financing under a loan deal signed with the European Investment Bank in late 2016. The company also said it will now be able to access €1.5 million under a €20 million convertible notes financing facility signed with Yorkville Advisors Global in October.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.